PDF herunterladen
Am J Perinatol
DOI: 10.1055/a-1819-1669
Original Article

Effect of Maternal Subclinical Hypothyroidism on Congenital Hypothyroidism Screening Results: A Retrospective Cohort Study

Sabriye Korkut
1   Department of Pediatrics, Division of Neonatology, Ankara City Hospital, University of Health Sciences, Ankara, Turkey
,
Nilgün Çaylan
2   Department of Child and Adolescents Health, Ministry of Health, General Directorate of Public Health, Ankara, Turkey
,
Ayse S. Özgü-Erdinç 
3   Department of Obstetrics and Gynecology, Ankara City Hospital, University of Health Sciences, Ankara, Turkey
,
Mustafa Ş. Akın
1   Department of Pediatrics, Division of Neonatology, Ankara City Hospital, University of Health Sciences, Ankara, Turkey
,
Meryem Ceyhan
3   Department of Obstetrics and Gynecology, Ankara City Hospital, University of Health Sciences, Ankara, Turkey
,
Fatih Kara
4   Ministry of Health, General Directorate of Public Health, Ankara, Turkey
,
Başak Tezel
2   Department of Child and Adolescents Health, Ministry of Health, General Directorate of Public Health, Ankara, Turkey
,
Şerife S. Oğuz
1   Department of Pediatrics, Division of Neonatology, Ankara City Hospital, University of Health Sciences, Ankara, Turkey
› Institutsangaben Funding None.
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Objectives This study aimed to evaluate the results of congenital hypothyroidism screening (CHS) in neonates born to women with subclinical hypothyroidism (SHT) during pregnancy and to identify maternal and neonatal characteristics associated with recall rate in CHS.

Study Design This retrospective cohort study included nonrefugee pregnant women and newborn pairs who underwent thyroid function tests during prenatal follow-up between 2014 and 2017 and had neonatal CHS records. The women were evaluated overall and divided into euthyroidism (ET) and SHT groups according to their thyroid function tests. The groups were compared in terms of CHS results. Neonates with thyroid-stimulating hormone (TSH) levels <5.5 mIU/L were considered “normal,” while those with values ≥5.5 mIU/L were “recall.”

Results The antenatal thyroid function data of a total of 22,383 pregnant women were analyzed. Of these, 71.6% were ET and 16.3% were diagnosed as SHT. Overall, the recall rate accounted for 5.34% of all CHS results and the recall rate was higher in the SHT group (7.10%) compared with the ET group (5.54%; p = 0.001). Being low birth weight (LBW) or large for gestation age (LGA), maternal TSH above the 97.5th percentile, and cesarean delivery increased the risk of recall in CHS (p ˂ 0.05).

Conclusion The recall rate was higher among the neonates of mothers with SHT. Being LBW or LGA, maternal TSH above the 97.5th percentile and cesarean delivery increased the risk of recall in CHS.

Key Points

  • SHT is the most common form of hypothyroidism in pregnancy.

  • TSH elevation is higher among the neonates of mothers with SHT.

  • Being LBW or LGA, and cesarean delivery also increase the risk of TSH elevation in infants.

Keywords

maternal - subclinical hypothyroidism - congenital hypothyroidism - screening - newborn

Note

This study has been selected as an oral presentation in Online National Neonatology Congress (UNEKO-28) on December 10–14, 2020.




Publikationsverlauf

Eingereicht: 14. Februar 2022

Angenommen: 31. März 2022

Accepted Manuscript online:
06. April 2022

Artikel online veröffentlicht:
06. Juni 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010; 31 (05) 702-755
    CrossrefPubMedGoogle Scholar
  • 2 Alexander EK, Pearce EN, Brent GA. et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during pregnancy and the postpartum. Thyroid 2017; 27 (03) 315-389
    CrossrefPubMedGoogle Scholar
  • 3 Stagnaro-Green A, Pearce E. Thyroid disorders in pregnancy. Nat Rev Endocrinol 2012; 8 (11) 650-658
    CrossrefPubMedGoogle Scholar
  • 4 Liu Y, Chen H, Jing C, Li F. The association between maternal subclinical hypothyroidism and growth, development, and childhood intelligence: a meta-analysis. J Clin Res Pediatr Endocrinol 2018; 10 (02) 153-161
    CrossrefPubMedGoogle Scholar
  • 5 Maraka S, Ospina NM, O'Keeffe DT. et al. Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis. Thyroid 2016; 26 (04) 580-590
    CrossrefPubMedGoogle Scholar
  • 6 Spencer L, Bubner T, Bain E, Middleton P. Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health. Cochrane Database Syst Rev 2015; (09) CD011263
    PubMedGoogle Scholar
  • 7 Shields BM, Knight BA, Hill A, Hattersley AT, Vaidya B. Fetal thyroid hormone level at birth is associated with fetal growth. J Clin Endocrinol Metab 2011; 96 (06) E934-E938
    CrossrefPubMedGoogle Scholar
  • 8 Medici M, de Rijke YB, Peeters RP. et al. Maternal early pregnancy and newborn thyroid hormone parameters: the Generation R study. J Clin Endocrinol Metab 2012; 97 (02) 646-652
    CrossrefPubMedGoogle Scholar
  • 9 Korevaar TI, Chaker L, Jaddoe VW, Visser TJ, Medici M, Peeters RP. Maternal and birth characteristics are determinants of offspring thyroid function. J Clin Endocrinol Metab 2016; 101 (01) 206-213
    CrossrefPubMedGoogle Scholar
  • 10 LaFranchi SH. Newborn screening strategies for congenital hypothyroidism: an update. J Inherit Metab Dis 2010; 33 (Suppl. 02) S225-S233
    CrossrefPubMedGoogle Scholar
  • 11 Varner MW, Mele L, Casey BM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Thyroid function in neonates of women with subclinical hypothyroidism or hypothyroxinemia. J Perinatol 2018; 38 (11) 1490-1495
    CrossrefPubMedGoogle Scholar
  • 12 Kuppens SM, Kooistra L, Wijnen HA. et al. Neonatal thyroid screening results are related to gestational maternal thyroid function. Clin Endocrinol (Oxf) 2011; 75 (03) 382-387
    CrossrefPubMedGoogle Scholar
  • 13 Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013; 13: 59
    CrossrefPubMedGoogle Scholar
  • 14 Stagnaro-Green A, Abalovich M, Alexander E. et al; American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21 (10) 1081-1125
    CrossrefPubMedGoogle Scholar
  • 15 De Groot L, Abalovich M, Alexander EK. et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97 (08) 2543-2565
    CrossrefPubMedGoogle Scholar
  • 16 Çaylan N, Tezel B, Özbaş S. et al. Neonatal thyroid-stimulating hormone screening as a monitoring tool for iodine deficiency in Turkey. J Clin Res Pediatr Endocrinol 2016; 8 (02) 187-191
    CrossrefPubMedGoogle Scholar
  • 17 Özon A, Tekin N, Şıklar Z. et al. Neonatal effects of thyroid diseases in pregnancy and approach to the infant with increased TSH: Turkish Neonatal and Pediatric Endocrinology and Diabetes Societies consensus report. Turk Pediatri Ars 2018; 53 (Suppl. 01) S209-S223
    PubMedGoogle Scholar
  • 18 Teng W, Shan Z, Patil-Sisodia K, Cooper DS. Hypothyroidism in pregnancy. Lancet Diabetes Endocrinol 2013; 1 (03) 228-237
    CrossrefPubMedGoogle Scholar
  • 19 Blatt AJ, Nakamoto JM, Kaufman HW. National status of testing for hypothyroidism during pregnancy and postpartum. J Clin Endocrinol Metab 2012; 97 (03) 777-784
    CrossrefPubMedGoogle Scholar
  • 20 Moreno-Reyes R, Glinoer D, Van Oyen H, Vandevijvere S. High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population-based study. J Clin Endocrinol Metab 2013; 98 (09) 3694-3701
    CrossrefPubMedGoogle Scholar
  • 21 Akarsu EAF, Altay M, Altun BU, et al. Guideline of The Turkey Endocrinology and Metabolism Society for the thyroid diseases diagnosis and treatment. 2020:107-114 Available at: https://file.temd.org.tr/Uploads/publications/guides/documents/20200929134733-2020tbl_kilavuzf527c34496.pdf?a=1.
  • 22 Vural M, Koc E, Evliyaoglu O. et al; Turkish Iodine Survey Group. Iodine status of Turkish pregnant women and their offspring: a national cross-sectional survey. J Trace Elem Med Biol 2021; 63: 126664
    CrossrefPubMedGoogle Scholar
  • 23 Yuan P, Wang Q, Huang R. et al. Clinical evaluation with self-sequential longitudinal reference intervals: pregnancy outcome and neonatal thyroid stimulating hormone level associated with maternal thyroid diseases. West Indian Med J 2013; 62 (01) 28-34
    PubMedGoogle Scholar
  • 24 Zhang Y, Du C, Wang W. et al. Effect of maternal and neonatal factors on neonatal thyroid stimulating hormone: results from a population-based prospective cohort study in China. J Trace Elem Med Biol 2018; 49: 151-156
    CrossrefPubMedGoogle Scholar
  • 25 Di Dalmazi G, Carlucci MA, Semeraro D. et al. A detailed analysis of the factors influencing neonatal TSH: results from a 6-year congenital hypothyroidism screening program. Front Endocrinol (Lausanne) 2020; 11: 456
    CrossrefPubMedGoogle Scholar
  • 26 Ng SM, Wong SC, Paize F. et al. Multivariate analyses of factors that affect neonatal screening thyroid stimulating hormone. J Pediatr Endocrinol Metab 2011; 24 (9-10): 727-732
    PubMedGoogle Scholar
  • 27 Segni M. Disorders of the thyroid gland in infancy, childhood and adolescence. In: Feingold KR, Anawalt B, Boyce A. et al, eds. Endotext. South Dartmouth, MA, MDText.com, Inc.; 2000
    Google Scholar
  • 28 Fisher DA. Hypothyroxinemia in premature infants: is thyroxine treatment necessary?. Thyroid 1999; 9 (07) 715-720
    CrossrefPubMedGoogle Scholar
  • 29 Trumpff C, Vandevijvere S, Moreno-Reyes R. et al. Neonatal thyroid-stimulating hormone level is influenced by neonatal, maternal, and pregnancy factors. Nutr Res 2015; 35 (11) 975-981
    CrossrefPubMedGoogle Scholar
  • 30 Thorpe-Beeston JG, Nicolaides KH, Snijders RJ, Felton CV, McGregor AM. Thyroid function in small for gestational age fetuses. Obstet Gynecol 1991; 77 (05) 701-706
    PubMedGoogle Scholar
  • 31 Bosch-Giménez VM, Palazón-Bru A, Blasco-Barbero Á, Juste-Ruiz M, Rizo-Baeza MM, Cortés-Castell E. Multivariate analysis of thyrotropin in preterm newborns based on adequacy of weight for gestational age. Thyroid 2017; 27 (01) 120-124
    CrossrefPubMedGoogle Scholar
  • 32 Liu C, Wang K, Guo J. et al. Small for gestational age is a risk factor for thyroid dysfunction in preterm newborns. BMC Pediatr 2020; 20 (01) 179
    CrossrefPubMedGoogle Scholar
  • 33 Lao TT, Lee CP. Gestational diabetes mellitus and neonatal hyperthyrotropinemia. Gynecol Obstet Invest 2002; 53 (03) 135-139
    CrossrefPubMedGoogle Scholar
  • 34 McElduff A, McElduff P, Wiley V, Wilcken B. Neonatal thyrotropin as measured in a congenital hypothyroidism screening program: influence of the mode of delivery. J Clin Endocrinol Metab 2005; 90 (12) 6361-6363
    CrossrefPubMedGoogle Scholar
  • 35 Wang Y, He Y, Zhuang L. et al. Effect of maternal and neonatal factors on neonatal thyroid screening results. Clin Lab 2018; 64 (09) 1445-1450
    PubMedGoogle Scholar
  • 36 Turan S, Bereket A, Angaji M. et al. The effect of the mode of delivery on neonatal thyroid function. J Matern Fetal Neonatal Med 2007; 20 (06) 473-476
    CrossrefPubMedGoogle Scholar
  • 37 Aktas ON, Gursoy T, Soysal E, Esencan E, Ercin S. Thyroid hormone levels in late preterm, early term and term infants: a study with healthy neonates revealing reference values and factors affecting thyroid hormones. J Pediatr Endocrinol Metab 2017; 30 (11) 1191-1196
    CrossrefPubMedGoogle Scholar
  • 38 Nili F, Hantoushzadeh S, Alimohamadi A, Shariat M, Rezaeizadeh G. Iodine-containing disinfectants in preparation for caesarean section: impact on thyroid profile in cord blood. Postgrad Med J 2015; 91 (1082): 681-684
    CrossrefPubMedGoogle Scholar
  • 39 Novaes Júnior M, Biancalana MM, Garcia SA, Rassi I, Romaldini JH. Elevation of cord blood TSH concentration in newborn infants of mothers exposed to acute povidone iodine during delivery. J Endocrinol Invest 1994; 17 (10) 805-808
    CrossrefPubMedGoogle Scholar
  • 40 Chan SS, Hams G, Wiley V, Wilcken B, McElduff A. Postpartum maternal iodine status and the relationship to neonatal thyroid function. Thyroid 2003; 13 (09) 873-876
    CrossrefPubMedGoogle Scholar